Skip to main content
SpringerLink
Log in

Influence of naloxone upon motor activity induced by psychomotor stimulant drugs

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Naloxone, an opioid receptor antagonist, attenuates a wide range of behavioral effects ofd-amphetamine, such as the stimulation of motor activity. To investigate the pharmacological selectivity of the naloxone/amphetamine interaction, we assessed the effects of naloxone (5.0 mg/kg SC) upon motor activity induced in rats by a range of psychomotor stimulant drugs with a mechanism of action either similar to or different from that ofd-amphetamine. Each of the drugs tested caused dose-dependent increases in both gross and fine activity. Naloxone attenuated the gross but not the fine activity response tod- andl-amphetamine, but had no influence upon the other catecholamine-releasing drugs, methamphetamine and phendimetrazine. In contrast, naloxone increased the gross but not the fine activity response to the catecholamine uptake inhibitors cocaine and mazindol, but had no effects upon the motor response to methylphenidate. The responses to other stimulant drugs (apomorphine, caffeine, scopolamine) were unaffected by naloxone pretreatment. The present findings extend the range of conditions under which naloxone and, by inference, endogenous opioid systems, modulate the behavioral response to psychomotor stimulants. However, the differential effects of naloxone upon the motor response to individual stimulant drugs support previous suggestions of fundamental differences in mechanisms of action among these compounds.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Acquis E, Meloni M, Di Chiara G (1993) Blockade of ·-opioid receptors in the nucleus accumbens prevents ethanol-induced stimulation of dopamine release. Eur J Pharmacol 230:239–241

    Google Scholar 

  • Adams PM, Beauchamp R, Alston C (1981) Potentiation of apomorphine andd-amphetamine effects by naloxone. Life Sci 28:629–634

    Google Scholar 

  • Andrews JS, Holtzman SG (1987a) Effects of naloxone and diprenorphine on amphetamine-stimulated behavior in guineapigs and rats. Neuropharmacology 26:1115–1120

    Google Scholar 

  • Andrews JS, Holtzman SG (1987b) The interaction ofd-amphetamine and naloxone differs for rats trained on separate fixed interval or fixed ratio schedules of reinforcement. Pharmacol Biochem Behav 26:167–171

    Google Scholar 

  • Arbuthnott GW, Fairbrother IS, Butcher SP (1991) Dopamine release and metabolism in the rat striatum: an analysis by “in vivo” brain microdialysis. Pharmacol Ther 48:281–293

    Google Scholar 

  • Bain GT, Kornetsky C (1987) Naloxone attenuation of the effect of cocaine on rewarding brain stimulation. Life Sci 40:1119–1125

    Google Scholar 

  • Balsara JJ, Nandal NV, Burte NP, Jadhav JH, Chandorkar AG (1984) Effects of naloxone on methamphetamine and apomorphine stereotypy and on haloperidol catalepsy in rats. Psychopharmacology 82:237–240

    Google Scholar 

  • Berger UV, Gu XF, Azmitia EC (1992) The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine,p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via common mechanism blocked by fluoxetine and cocaine. Eur J Pharmacol 215:153–160

    Google Scholar 

  • Berkowitz BA, Ngai SH, Mempstead J, Spector S (1975) Disposition of naloxone: use of a new radioimmunoassay. J Pharmacol Exp Ther 195:499–504

    Google Scholar 

  • Bilsky EJ, Montegut MJ, DeLong CL, Reid LD (1992) Opioidergic modulation of cocaine conditioned place preferences. Life Sci Pharmacol Lett 50:PL-85–PL-90

    Google Scholar 

  • Byck R, Ruskis A, Ungerer J, Jatlow P (1982) Naloxone potentiates cocaine effect in man. Psychopharmacol Bull 18:214–215

    Google Scholar 

  • Chait LD, Uhlenhuth EH, Johanson CE (1986) The discriminative stimulus and subjective effects of phenylpropanolamine, mazin dol andd-amphetamine in humans. Pharmacol Biochem Behav 24:1665–1672

    Google Scholar 

  • Chait LD, Uhlenhuth EH, Johanson CE (1987) Reinforcing and subjective effects of several anorectics in normal human volunteers. J Pharmacol Exp Ther 242:777–783

    Google Scholar 

  • Corrigall WA, Coen KM (1991) Opiate antagonists reduce cocaine but not nicotine self administration. Psychopharmacology 104:167–170

    Google Scholar 

  • Corwin RL, Woolverton WL, Schuster CR, Johanson CE (1987) Anorectics effects on food intake and self-administration in rhesus monkeys. Alcohol Drug Res 7:351–361

    Google Scholar 

  • DeRossett SE, Holtzman SG (1982) Effects of naloxone and diprenorphine on spontaneous activity in rats and mice. Pharmacol Biochem Behav 17:347–351

    Google Scholar 

  • Dettmar PW, Cowan A, Walter DS (1978) Naloxone antagonises behavioral effects ofd-amphetamine in mice and rats. Neuropharmacology 17:1041–1044

    Google Scholar 

  • Dewar D, Jenner PJ, Marsden CD (1987) Effects of opioid agonist drugs on the in vitro release of [3H]GABA, [3H]dopamine and [3H]5-HT from slices of rat globus pallidus. Biochem Pharmacol 36:1738–1741

    Google Scholar 

  • Di Chiara G, Imperato A (1988a) Opposite effects ofmu andkappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244:1067–1080

    Google Scholar 

  • Di Chiara G, Imperato A (1988b) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274–5278

    Google Scholar 

  • Esposito RU, Perry W, Kornetsky C (1991) Effects ofd-amphetamine and naloxone on brain stimulation reward. Psychopharmacology 69:187–191

    Google Scholar 

  • Ettenberg A, Petit HO, Bloom FE, Koob GF (1982) Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems. Psychopharmacology 78:204–209

    Google Scholar 

  • Feigenbaum J, Yanai J, Moon B, Klawans H (1983) Effects of naloxone and morphine on dopamine agonist-induced stereotypy in rats and guinea-pigs. Neuropharmacology 22[12A]:1369–1376

    Google Scholar 

  • Ferris RM, Tang F, Maxwell R (1972) A comparison of the capacities of isomers of amphetamine, deoxypipradrol and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta. J Exp Ther 181:407–416

    Google Scholar 

  • Fischmann MW, Schuster CR, Resnekov L, Shick JFE, Krasnegor NA, Fennell W, Freedman DX (1976) Cardiovascular and subjective effects of intravenous cocaine administration in humans. Arch Gen Psychiatry 33:983–989

    Google Scholar 

  • Franklin KBJ, Robertson A (1982) Effects and interactions of naloxone and amphetamine on self-stimulation of the prefrontal cortex and dorsal tegmentum. Pharmacol Biochem Behav 16:433–436

    Google Scholar 

  • George FR, Porrino LJ, Ritz MC, Goldberg SR (1991) Inbred rat strain comparisons indicate different sites of action for cocaine and amphetamine locomotor stimulant effects. Psychopharmacology 104:457–462

    Google Scholar 

  • Giorgi O, Pibiri MG, Ongini E, Trampus M, Biggio G (1991) The neutral endopeptidase-24.11 (enkephalinase) inhibitor, SCH 32615, increases dopamine metabolism in the nucleus accumbens of the rat. Eur J Pharmacol 196:137–142

    Google Scholar 

  • Graybiel AM, Moratalla R, Robertson HA (1990) Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc Natl Acad Sci USA 87:6912–6916

    Google Scholar 

  • Green AR, De Souza RJ, Williams JL, Murray TK, Cross AJ (1992) The neurotoxic effects of methamphetamine on 5-hydroxytryptamine and dopamine in brain: evidence for the protective effect of chlormethiazole. Neuropharmacology 31:315–321

    Google Scholar 

  • Harris RA, Snell D (1980) Interactions between naltrexone and non-opiate drugs evaluated by schedule-controlled behavior. Neuropharmacology 19:1087–1093

    Google Scholar 

  • Heikkila RE, Orlanski H, Cohen G (1975) Studies on the distinction between uptake inhibition and release of [3H]dopamine in rat brain tissue slices. Biochem Pharmacol 24:847–852

    Google Scholar 

  • Heikkila RE, Cabbat FS, Mytilineou C (1977) Studies on the capacity of mazindol and dita to act as uptake inhibitors or releasing agents for [3H]biogenic amine in rat brain tissue slices. Eur J Pharmacol 45:329–333

    Google Scholar 

  • Hitzemann R, Curell J, Hom D, Loh H (1982) Effects of naloxone ond-amphetamine and apomorphine-induced behavior. Neuropharmacology 21:1005–1011

    Google Scholar 

  • Hoffman BB, Lefkowitz RJ (1990) Catecholamines and sympathomimetic drugs. In: Goodman Gilman A, Rall TW, Nies AS, Taylor P (eds) Goodman and Gilman's The pharmacological basis of therapeutics. Macmillan, New York, pp 187–220

    Google Scholar 

  • Holtzman SG (1974) Behavioral effects of separate and combined administration of naloxone andd-amphetamine. J Pharmacol Exp Ther 189:51–60

    Google Scholar 

  • Holtzman SG (1976) Comparison of the effects of morphine, pentazocine, cyclazocine and amphetamine on intracranial self-stimulation in the rat. Psychopharmacologia 46:223–227

    Google Scholar 

  • Hooks MS, Jones DNC, Justice JB Jr Holtzman SG (1992) Naloxone reduces amphetamine-induced stimulation of locomotor activity and in vivo dopamine release in the striatum and nucleus accumbens. Pharmacol Biochem Behav 42:765–770

    Google Scholar 

  • Houdi AA, Bardo MT, Van Loon GR (1989) Opioid mediation of cocaine-induced hyperactivity and reinforcement. Brain Res 497:195–198

    Google Scholar 

  • Huey LY, Janowsky DS, Judd LL, Roitman NA, Clopton PL, Segal D, Hall L, Parker D (1980) The effects of naloxone on methylphenidate-induced mood and behavioral changes: a negative study. Psychopharmacology 67:125–130

    Google Scholar 

  • Jiang Q, North RA (1992) Pre- and postsynaptic inhibition of opioids in rat striatum J Neurosci 12:356–361

    Google Scholar 

  • Johnson SW, North RA (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12:483–488

    Google Scholar 

  • Jones DNC, Holtzman SG (1992a) Interaction between opioid antagonists and amphetamine: Evidence for mediation by centraldelta opioid receptors. J Pharmacol Exp Ther 262[2]:638–645

    Google Scholar 

  • Jones DNC, Holtzman SG (1992b) Effects of naloxone infusion upon spontaneous and amphetamine-induced activity. Eur J Pharmacol 221:161–165

    Google Scholar 

  • Killian AK, Bonese K, Schuster CR (1978) The effects of naloxone on behavior maintained by cocaine and heroin injections in the rhesus monkey. Drug Alcohol Depend 3:243–251

    Google Scholar 

  • Kleven MS, Seiden LS (1992) Methamphetamine-induced neurotoxicity: structure activity relationships. Ann NY Acad Sci 654:292–301

    Google Scholar 

  • Kosten T, Silverman DG, Fleming J, Kosten TE, Gawin FH, Compton M, Jatlow P, Byck R (1993) Intravenous cocaine challenges during naltrexone maintenance: a preliminary study. Biol Psychiatry (in press)

  • Kuczenski R, Segal D (1989) Concomitant characterisation of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis J Neurosci 9[6]:2051–2065

  • Kuczenski R, Segal DS (1992) Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine. J Pharmacol Exp Ther 262:1085–1094

    Google Scholar 

  • Kuczenski R, Segal DS, Aizenstein ML (1991) Amphetamine, fencamfamine, and cocaine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics. J Neurosci 11:2703–2712

    Google Scholar 

  • Leone P, Pocock D, Wise RA (1991) Morphine-dopamine interaction: ventral tegmental morphine increases nucleus accumbens dopamine release. Pharmacol Biochem Behav 39:469–472

    Google Scholar 

  • Lubetski C, Chesselet M-F, Glowinski J (1982) Modulation of dopamine release in rat striatal slices bydelta opiate agonists. J Pharmacol Exp Ther 222:435–440

    Google Scholar 

  • Manzanares J, Lookingland KJ, Lavigne SD, Moore KE (1991) Activation of tuberohypophysial dopamine neurons following intracerebroventricular administration of the selectivekappa opioid receptor antagonist norbinaltorphimine. Life Sci 48:1143–1149

    Google Scholar 

  • McGregor IS, Atrens DM, Jacson DM (1992) Cocaine facilitation of prefrontal cortex self-stimulation: a microstructural and pharmacological analysis. Psychopharmacology 106:239–247

    Google Scholar 

  • McMillen BA (1983) CNS stimulants: two distinct mechanisms of action for amphetamine-like drugs. TIPS 5:429–432

    Google Scholar 

  • Mello NK, Mendelson JH, Bree MP, Lukas SE (1990) Buprenorphine and naltrexone effects on cocaine self administration by rhesus monkeys. J Pharmacol Exp Ther 254:926–939

    Google Scholar 

  • Menkens K, Bilsky EJ, Wild KD, Portoghese PS, Reid LD, Porreca F (1992) Cocaine place preference is blocked by the δ-opioid receptor antagonist, naltrindole. Eur J Pharmacol 219:345–346

    Google Scholar 

  • Misra AL, Pontani RB, Vadlamini NL, Mule SJ (1976) Physiological disposition and biotransformation of [ally-1′,3′-14C] naloxone. J Pharmacol Exp Ther 196:257–268

    Google Scholar 

  • Moon BH, Feigenbaum JJ, Carson PE, Klawans HL (1980) The role of dopaminergic mechanisms in naloxone-induced inhibition of apomorphine-induced stereotyped behavior. Eur J Pharmacol 61:71–78

    Google Scholar 

  • Peat MA, Warren PF, Bakhit C, Gibb JW (1985) The acute effects of methamphetamine, amphetamine andp-chloroamphetamine on the cortical serotonergic system of the rat brain: evidence for differences in the effects of methamphetamine and amphetamine. Eur J Pharmacol 116:11–16

    Google Scholar 

  • Petit F, Hamon M, Fournie-Zaluski MC, Roques BP (1986) Further evidence for a role ofdelta opiate receptor in the presynaptic regulation of newly synthesised dopamine release. Eur J Pharmacol 126:1–9

    Google Scholar 

  • Quock RM, Lucas TS, Hartl TJ (1983) Potentiation of apomorphine-induced stereotypies by naloxone andl-prolyl-l-leucylglycinamide. Pharmacol Biochem Behav 19:49–52

    Google Scholar 

  • Ramsey NF, Van Ree JM (1991) Intracerebroventricular naltrexone treatment attenuates aquisition of intravenous cocaine self-administration in rats. Pharmacol Biochem Behav 40:807–810

    Google Scholar 

  • Ricaurte GA, McCann UD (1992) Neurotoxic amphetamine analogues: effects in monkeys and implication for humans. Ann NY Acad Sci 654:371–382

    Google Scholar 

  • Santiago M, Westerink BHC (1992) The role of GABA receptors in the control of nigrostriatal dopaminergic neurons: dual-probe microdialysis study in awake rats. Eur J Pharmacol 219:175–181

    Google Scholar 

  • Schaefer GJ, Michael RP (1990) Interactions of naloxone with morphine, amphetamine and phencyclidine on fixed interval responding for intracranial self-stimulation in rats. Psychopharmacology 102:263–268

    Google Scholar 

  • Segal DS, Browne RG, Arnsten A, Derrington DC (1979) Characteristics of β-endorphin-induced behavioral activation and immobilization. In: Usdin E, Bunney WE Jr, Kline DS (eds)h Endorphins in mental health research. Oxford University Press, New York, pp 307–324

    Google Scholar 

  • Seiden LS, Ricaurte GA (1987) Neurotoxicity of methamphetamine and related drugs. In Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 359–366

    Google Scholar 

  • Sharp LG, Pilotte NS, Mitchell WM, DeSouza EB (1991) Withdrawal of repeated cocaine decreases autoradiographic [3H]mazindol-labelling of dopamine transport in rat. Eur J Pharmacol 203:141–144

    Google Scholar 

  • Spanagel R, Herz A, Shippenberg TS (1990a) The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J Neurochem 55:1734–1740

    Google Scholar 

  • Spanagel R, Herz A, Shippenberg TS (1990b) Identification of the opioid receptor types mediating beta-endorphin induced alterations in dopamine release in the nucleus accumbens. Eur J Pharmacol 190:177–184

    Google Scholar 

  • Spealman RD, Bergman J (1992) Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids. J Pharmacol Exp Ther 262:607–615

    Google Scholar 

  • Steketee JD, Kalivas PW (1992) Microinjection of the D2 agonist quinpirole into the A10 dopamine region blocks amphetamine-, but not cocaine-stimulated motor activity. J Pharmacol Exp Ther 261:811–818

    Google Scholar 

  • Swerdlow NR, Vaccarino FJ, Koob GF (1985) Effects of naloxone on heroin- amphetamine- and caffeine-stimulated locomotor activity in the rat. Pharmacol Biochem Behav 23:499–501

    Google Scholar 

  • Trovero F, Herve D, Desban M, Glowinski J, Tassin J-P (1990) Striatal opiatemu-receptors are not located on dopamine nerve endings in the rat. Neuroscience 39[2]:313–321

    Google Scholar 

  • Trujillo KA, Belluzi JD, Stein L (1991) Naloxone blockade of amphetamine place preference conditioning. Psychopharmacology 104:265–274

    Google Scholar 

  • Walker L, McGlynn T, Grey CG, Ragozzino M, Gold PE (1991) Naloxone modulates the behavioral effects of cholinergic agonists and antagonists. Psychopharmacology 105:57–62

    Google Scholar 

  • Wenger G (1980) Cumulative dose-response curves in behavioral pharmacology. Pharmacol Biochem Behav 13:647–651

    Google Scholar 

  • Winslow JT, Miczek KA (1988) Naltrexone blocks amphetamine-induced hyperactivity, but not disruption of social and agonistic behavior in mice and squirrel monkeys. Psychopharmacology 96:493–499

    Google Scholar 

  • Wood PL (1983) Opioid regulation of CNS dopaminergic pathways: a review of methodology, receptor types, regional variations and specific differences. Peptides 4:595–601

    Google Scholar 

  • Wood PL, Iyengar S (1988) Central actions of opiates and opioid peptides: in vivo evidence for opioid receptor multiplicity. In: Pasternak GW (ed.) The opiate receptors. Humana Press, Clifton, pp 307–356

    Google Scholar 

  • Zetterstrom T, Sharp T, Ungerstedt U (1986) Further evaluation of the mechanism by which amphetamine reduces striatal dopamine metabolism: a brain dialysis study. Eur J Pharmacol 132:1–9

    Google Scholar 

Download references

Author information

Author notes

  1. Declan N. C. Jones

    Present address: Unit for Behavioral Psychopharmacology, University of Hertfordshire, College Lane, AL10 9AB, Hatfield, Hertfordshire, UK

Authors and Affiliations

  1. Department of Pharmacology, Emory University School of Medicine, 30322, Atlanta, GA, USA

    Declan N. C. Jones & Stephen G. Holtzman

Authors
  1. Declan N. C. Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen G. Holtzman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jones, D.N.C., Holtzman, S.G. Influence of naloxone upon motor activity induced by psychomotor stimulant drugs. Psychopharmacology 114, 215–224 (1994). https://doi.org/10.1007/BF02244839

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02244839

Key words

Search

Navigation